Trial Profile
The role of neurokinin B receptor antagonist, AZD4901 in the control of follicle development in healthy women with regular menstrual cycles
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2017
Price :
$35
*
At a glance
- Drugs Pavinetant (Primary)
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- 12 Oct 2017 Results assessing role of AZD4901 in the control of follicle development in healthy women with regular menstrual cycles, were published in the Journal of Clinical Endocrinology and Metabolism.
- 10 Oct 2016 New trial record